AbbVie (ABBV) Dividends payables (2013 - 2015)
AbbVie (ABBV) reported Dividends payables of $924.0 million for Q4 2015, up 16.81% year-over-year from $791.0 million in Q4 2014, and up 16.81% quarter-over-quarter from $791.0 million in Q4 2014.
AbbVie (ABBV) Dividends payables (2013 - 2015) Analysis & Trends
AbbVie (ABBV) has 3 years of Dividends payables data on file, last reported at $924.0 million in Q4 2015.
- Dividends payables for Q4 2015 came in at $924.0 million, up 16.81% year-over-year; the trailing twelve-month figure through Dec 2015 was $924.0 million (up 16.81% YoY), and the FY2015 annual result was $924.0 million, up 16.81% from the prior year.
- Dividends payables grew to $924.0 million in Q4 2015 per ABBV's latest filing, from $791.0 million in the prior quarter.
- Over five years, Dividends payables peaked at $924.0 million in Q4 2015 and troughed at $643.0 million in Q4 2013.
- A 3-year average of $786.0 million and a median of $791.0 million in 2014 frame the typical range for Dividends payables.
- The sharpest annual moves came in 2014 and 2015: Dividends payables climbed 23.02% in 2014, then climbed 16.81% in 2015.
- A 3-year view of Dividends payables shows it stood at $643.0 million in 2013, then rose by 23.02% to $791.0 million in 2014, then rose by 16.81% to $924.0 million in 2015.
- Business Quant data shows ABBV's Dividends payables at $924.0 million in Q4 2015, $791.0 million in Q4 2014, and $643.0 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 2.14 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | - |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 109.78 Bn | 109.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 924.00 Mn |
| Dec 31, 2014 | 791.00 Mn |
| Dec 31, 2013 | 643.00 Mn |